SHED-Exo Proteomics and Osteoporosis Treatment Efficacy

Research from 2026 investigates the therapeutic effect of stem cell-derived exosomes on age-related osteoporosis. The dataset likely contains proteomic profiles of SHED-Exo and results from in vitro and in vivo experiments with senescent bone marrow mesenchymal stem cells and osteoporotic mice. Findings indicate the exosomes activate mitophagy and enhance osteogenic differentiation, offering a potential nanotherapeutic.

Use Cases

• [Analyzing exosomal protein enrichment] based on proteomic profiling of SHED-Exo
• [Modeling therapeutic efficacy] based on in vivo micro-computed tomography and molecular analysis of bone tissue
• [Studying mitochondrial function restoration] based on in vitro assays of senescent BMSCs
• [Investigating osteogenic differentiation markers] based on molecular analyses of treated cells and tissue

Strengths

• Dataset is openly licensed under CC-BY-4.0, facilitating reuse and sharing
• Research design includes both in vitro cell studies and in vivo mouse models, providing multi-level evidence
• Cross-platform presence on figshare indicates established sharing and potential for visibility

Limitations

• Column names and a precise row count are not provided, limiting understanding of data structure
• Metadata completeness is low, with unknown organization and sparse column details
• The dataset's temporal coverage is unclear beyond the 2026 publication date

Provenance

Source

Kuan Yang

Collection Method

Experimental study involving isolation and proteomic profiling of exosomes, followed by in vitro and in vivo therapeutic validation.

Freshness

Last updated on 2026-03-23